Acorda Therapeutics(ACOR) - 2023 Q1 - Earnings Call Transcript

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Tierney Saccavino - EVP, Corporate Communications Ron Cohen - Founder, CEO, President & Director Michael Gesser - CFO Conference Call Participants Operator Welcome to Acorda Therapeutics First Quarter 2023 Financial and Business Update. [Operator Instructions]. Please be advised that this call is being recorded at the company's request. I will now introduce your host for today's call, Tierne ...